These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31895625)

  • 1. A Drug Repurposing and Protein-Protein Interaction Network Study of Ribosomopathies Using Yeast as a Model System.
    Ertekin E; Gencturk E; Kasim M; Ulgen KO
    OMICS; 2020 Feb; 24(2):96-109. PubMed ID: 31895625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Identification of Protein Targets of Sub5 Using
    Shah P; Chen CS
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribosomopathies: New Therapeutic Perspectives.
    Orgebin E; Lamoureux F; Isidor B; Charrier C; Ory B; Lézot F; Baud'huin M
    Cells; 2020 Sep; 9(9):. PubMed ID: 32932838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO Platform.
    Hudson ML; Samudrala R
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33925237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug repurposing improves disease targeting 11-fold and can be augmented by network module targeting, applied to COVID-19.
    Rivero-García I; Castresana-Aguirre M; Guglielmo L; Guala D; Sonnhammer ELL
    Sci Rep; 2021 Oct; 11(1):20687. PubMed ID: 34667255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational Analysis of the Chaperone Interaction Networks.
    Kumar A; Rizzolo K; Zilles S; Babu M; Houry WA
    Methods Mol Biol; 2018; 1709():275-291. PubMed ID: 29177666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hox protein interactions: screening and network building.
    Bergiers I; Lambert B; Daakour S; Twizere JC; Rezsohazy R
    Methods Mol Biol; 2014; 1196():319-48. PubMed ID: 25151173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for Discovering and Targeting Druggable Protein-Protein Interfaces and Their Application to Repurposing.
    Ozdemir ES; Halakou F; Nussinov R; Gursoy A; Keskin O
    Methods Mol Biol; 2019; 1903():1-21. PubMed ID: 30547433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting drug-target interaction network using deep learning model.
    You J; McLeod RD; Hu P
    Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying essential proteins based on sub-network partition and prioritization by integrating subcellular localization information.
    Li M; Li W; Wu FX; Pan Y; Wang J
    J Theor Biol; 2018 Jun; 447():65-73. PubMed ID: 29571709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribosomopathies: how a common root can cause a tree of pathologies.
    Danilova N; Gazda HT
    Dis Model Mech; 2015 Sep; 8(9):1013-26. PubMed ID: 26398160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying protein complexes based on node embeddings obtained from protein-protein interaction networks.
    Liu X; Yang Z; Sang S; Zhou Z; Wang L; Zhang Y; Lin H; Wang J; Xu B
    BMC Bioinformatics; 2018 Sep; 19(1):332. PubMed ID: 30241459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tor1 and CK2 kinases control a switch between alternative ribosome biogenesis pathways in a growth-dependent manner.
    Kos-Braun IC; Jung I; Koš M
    PLoS Biol; 2017 Mar; 15(3):e2000245. PubMed ID: 28282370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel drug targets for diamond-blackfan anemia based on RPS19 gene mutation using protein-protein interaction network.
    Khan A; Ali A; Junaid M; Liu C; Kaushik AC; Cho WCS; Wei DQ
    BMC Syst Biol; 2018 Apr; 12(Suppl 4):39. PubMed ID: 29745857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing.
    Issa NT; Kruger J; Wathieu H; Raja R; Byers SW; Dakshanamurthy S
    BMC Bioinformatics; 2016 May; 17(1):202. PubMed ID: 27151405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-level bioinformatics resources support drug target discovery of protein-protein interactions.
    Liu JX; Zhang X; Huang YQ; Hao GF; Yang GF
    Drug Discov Today; 2024 May; 29(5):103979. PubMed ID: 38608830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex network theory for the identification and assessment of candidate protein targets.
    McGarry K; McDonald S
    Comput Biol Med; 2018 Jun; 97():113-123. PubMed ID: 29715596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of essential proteins from weighted protein-protein interaction networks.
    Li M; Wang JX; Wang H; Pan Y
    J Bioinform Comput Biol; 2013 Jun; 11(3):1341002. PubMed ID: 23796179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative proteomics and network analysis of SSA1 and SSB1 deletion mutants reveals robustness of chaperone HSP70 network in Saccharomyces cerevisiae.
    Jarnuczak AF; Eyers CE; Schwartz JM; Grant CM; Hubbard SJ
    Proteomics; 2015 Sep; 15(18):3126-39. PubMed ID: 25689132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network simulation reveals significant contribution of network motifs to the age-dependency of yeast protein-protein interaction networks.
    Liang C; Luo J; Song D
    Mol Biosyst; 2014 Jul; 10(9):2277-88. PubMed ID: 24964354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.